Cancer Stem Cell News Volume 9.38 | Oct 7, 2020







2020-10-07 | CSCN 9.38


Cancer Stem Cell News by STEMCELL Technologies
Vol. 9.38 – 07 October, 2020
TOP STORY

The
RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells

Researchers interrogated N6-methyladenosine (m5A) mRNA modifications in glioma stem cells by methyl RNA-immunoprecipitation followed by sequencing and transcriptome analysis, finding transcripts marked by m6A often upregulated compared to normal neural stem cells.
[Cancer Discovery]

Abstract

Watch the webinar where Dr. Suzan Imren discusses factors affecting the balance between HSC self-renewal and leukemic transformation
PUBLICATIONSRanked by the impact factor of the journal

Epigenetic
Modulator Inhibition Overcomes Temozolomide Chemoresistance and Antagonizes Tumor Recurrence of Glioblastoma

Investigators identified a specific glioblastoma multiforme stem-like cells subset and showed that activity of these cells was positively regulated by stabilization of methyl CpG binding domain 3 protein.
[Journal of Clinical Investigation]

Full ArticleGraphical Abstract

Immune
Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection

Extracellular matrix-rich tumors exhibited a stem cell-like gene expression profile and superior tumor-initiating capacity, whereas such features were absent in responder tumors.
[Cancer Immunology Research]

AbstractFull Article

Ablation
of Neuropilin-1 Improves the Therapeutic Response in Conventional Drug-Resistant Glioblastoma Multiforme

Scientists observed that patient-derived glioblastoma cells expressing shRNAs of VEGF or neuropilin-1 attenuated cancer stem cell markers, inhibited the tumor-initiating cell’s neurosphere-forming capacity, and migration.
[Oncogene]

Abstract

Small
GTPase RAB6 Deficiency Promotes Alveolar Progenitor Cell Renewal and Attenuates PM2.5-Induced Lung Injury and Fibrosis

Investigators demonstrated that knockout of RAB6 inhibited pulmonary fibrosis, oxidative stress, and type 2 alveolar epithelial cells (AEC2) cell death in fine particulate matter (PM2.5)-injured mice. In addition, knockout of RAB6 decreased Dickkopf 1 autocrine and activated proliferation, self-renewal, and wnt/β-catenin signaling of PM2.5-injured AEC2 cells.
[Cell Death & Disease]

Full Article

Long-Term Helicobacter pylori
Infection Switches Gastric Epithelium Reprogramming Towards Cancer Stem Cell-Related Differentiation Program in Hp-Activated Gastric Fibroblast-TGFβ Dependent Manner

TGFβ1 rich secretome from Helicobacter pylori-reprogrammed fibroblasts prompted phenotypic plasticity and epithelial–mesenchymal transition (EMT) of gastric epithelium, inducing pro-neoplastic expansion of post-EMT cells in the presence of low TGFβR1 and TGFβR2 activity.
[Microorganisms]

AbstractFull Article

TIMP-2
Regulates Proliferation, Invasion and STAT3-Mediated Cancer Stem Cell-Dependent Chemoresistance in Ovarian Cancer Cells

FT282, JHOS2 and OVCAR4 cells were transiently transfected with either single or pooled TIMP-2 siRNAs. The expression of different genes after TIMP-2 knock down or in response to chemotherapy was determined at the mRNA level by quantitative real time PCR and at the protein level by immunofluorescence.
[BMC Cancer]

Abstract

Aspirin
Overcomes Cisplatin Resistance in Lung Cancer by Inhibiting Cancer Cell Stemness

Scientists used aspirin, a nonselective COX inhibitor, with cisplatin for several hours in cells and days in vivo, and studied the inhibition against human cisplatin‐resistant H460 cells.
[Thoracic Cancer]

Full Article

Tumor-Associated Macrophages Derived from Cancer Stem Cells

This study displayed histological and immunohistochemical analyses of a malignant tumor model developed from cancer stem cells converted from human iPSCs in a cancer microenvironment prepared from the conditioned medium of a pancreatic cancer cell line.
[Acta Histochemica]

Full Article


Scientific resources to support your cancer research. Learn More!
REVIEWS

Targeting
Mitochondrial Respiration for the Treatment of Acute Myeloid Leukemia

Scientists discuss the relative dependency that acute myeloid leukemia (AML) cells have on mitochondrial function, and the ability to pivot this reliance to target important subsets of AML cells, including leukemia stem cells.
[Biochemical Pharmacology]

AbstractGraphical Abstract

Role of Autophagy in Cancer Cell Response to Nucleolar and Endoplasmic Reticulum Stress

The authors give an overview of the complex role of nucleolar and endoplasmic reticulum stress-response mechanisms in the regulation of autophagy in cancer and cancer treatment.
[International Journal of Molecular Sciences]

Full Article
INDUSTRY AND POLICY NEWS

Aprea
Therapeutics Receives OK from FDA to Initiate Phase 1 Clinical Studies for Next-Generation Mutant p53 Reactivator, APR-548

Aprea Therapeutics, Inc. announced that the FDA has accepted the Company’s Investigational New Drug application for APR-548 to treat TP53 mutant myelodysplastic syndromes. APR-548 is a next-generation small molecule reactivator of mutant p53 that is being developed for oral administration.
[Aprea Therapeutics, Inc.]

Press Release

FEATURED EVENT

International Chemical Biology Society (ICBS) 2020 Conference

November 11 – November 13
Virtual


> See All Events

JOB OPPORTUNITIES

Postdoctoral
Scientists – Stem Cell Factors in Epithelial Cancers

The University of Chicago – Location

Research Fellow – Pancreatic and Liver Cancers

The Mayo Clinic – Jacksonville, Florida, United States


Postdoctoral Fellow – Stem Cells and Cancer

Albert Einstein College of Medicine – New York, New York, United States

Assistant/Associate
Professor – Center for Molecular Medicine

The University of Georgia – Athens, Georgia, United States

Postdoctoral Position – Human Pluripotent Stem Cells, Hematopoiesis and Leukemia

Icahn School of Medicine at Mount Sinai – New York City, New York, United States

> See All Jobs

Submit an article, publication, job or event
Brought to you by
stemcell-logo-for newsletter-2
Science News Cancer Stem Cell News
Archives Contact Us
Cancer Stem Cell News Twitter


0
Share